Download Report

Action Mesothelioma Day
Organised by the
Greater Manchester Asbestos Victims Support Group
Each year, hundreds of people gather in cities across the UK to raise
awareness of mesothelioma, to call for better treatment and care for
mesothelioma patients, for prevention of exposure to asbestos, and to ban
the export of asbestos to developing countries
Each year in Manchester, families affected by asbestos disease release
doves as a public act of remembrance of all those who have died from
mesothelioma and attend a public meeting.
Everyone is welcome to attend the dove release in Lincoln Square and the
meeting in the Town Hall followed by tea and coffee.
Lincoln Square is off Brazennose Street, close to Manchester Town Hall.
Friday 3rd July 2015
12.30pm
For more information Tel: 0161 636 7555
Greater Manchester Asbestos Victims Support Group
Windrush Millennium Centre
70 Alexandra Rd.
Manchester M16 7WD
[email protected]
Join Us
Action Mesothelioma Day
Friday 3rd July
12.30pm
Lincoln Square
Off Brazennose Street
Release of Sponsored Doves
In memory of those who have died from Mesothelioma
Public Meeting
Mesothelioma Research-Hope for the
Future?
Professor Luciano Mutti
Panel of experts including Dr Paul Taylor, Consultant
Respiratory Physician, Wythenshawe Hospital and Lorraine
Creech, Mesothelioma UK Nurse.
Manchester Town Hall
1pm —2pm
Mesothelioma Research—hope for the future?
In May 2016, the International Mesothelioma Interest Group (IMIG)
will meet in Birmingham. This conference, held every two years,
brings together the world’s leading researchers and experts in
mesothelioma, to share information on the latest research and raise
awareness about the dangers of asbestos.
Mesothelioma is an incurable cancer of the pleura (lining of the
lung). The only known cause is asbestos which was widely used in
the UK after the second world war, especially in construction and
industry. The UK has the highest rates of mesothelioma in the
world. And the number of new cases keep rising. Now, more than
ever, sufferers of this disease and their families need hope, hope not
only for better treatments but ultimately a cure .
The IMIG Conference in 2016 will be the first ever held in the UK, a
great honour and a recognition of the exciting and promising work
of mesothelioma researchers in the UK. There is a feeling of real
optimism amongst researchers that their increased understanding
of the disease has opened up the possibility of significant advances
in treatment and the search for a cure.
But funding is urgently needed to turn this optimism into reality. For
too long mesothelioma research has been the poor relation when
funding decisions have been made. Most mesothelioma victims
contracted this disease simply because they went to work to provide
for their families. They were not properly protected at work despite
the dangers of asbestos being known by Government and
employers. They were let down then—we must ensure they are not
let down again by the failure to fund essential research.
We invite you to join us at our rally and dove release in Lincoln
Square followed by our public meeting to hear about the latest
developments in mesothelioma research from Professor Mutti, after
which a panel of experts will answer your questions on research and
current treatments.
Luciano Mutti
Professor Luciano Mutti graduated in Medicine in
1982 and has specialised in respiratory medicine,
oncology and, in particular, mesothelioma. From
1999 – 2014 he was Head of the Department of
Medicine and the Lab of Clinical Oncology at Vercelli
General Hospital in Italy. Since 2014 he has been
Chair in Cancer Research and Honorary Consultant at
Royal Salford University Hospital.
An author of over a hundred articles on cancer research, Professor
Mutti is at the forefront of international mesothelioma research
today and is a committed campaigner for justice for asbestos victims
and the search for a cure for mesothelioma.
He is the Italian Director of the International Mesothelioma Interest
Group (IMIG) and on the organising committee for IMIG 2016 in the
UK. He has worked closely with asbestos victims groups in Italy,
Europe and the USA.
Lorraine Creech
Mesothelioma UK Nurse
“It is encouraging to see the growth of research
into mesothelioma with trials ranging from
drug treatments to halt the growth of the
disease to the early intervention of palliative care to improve
symptoms and quality of life.
These trials give hope for precision medicine in the near future and
better survival outcomes for those who are suffering with the illness.
As a health care professional it is inspiring and motivating to know
that research is being conducted in the UK and many other
countries to help improve treatment."